NEW YORK (GenomeWeb News) – Bruker said in a filing with the US Securities and Exchange Commission today that it has regained compliance with certain Nasdaq regulations.
The firm received a letter from Nasdaq on March 25, informing it that it was not in compliance with the stock market's rule that a firm must have at least three independent directors on its audit committee. The letter came after Bruker announced that Collin D'Silva, an independent director and member of the firm's audit committee, had resigned.
Nasdaq sent another letter to Bruker on April 1, which informed the firm that it also was not in compliance with a rule that the majority of its board must be comprised of independent directors.
The firm regained compliance with both rules after its election last week of Charles Wagner to serve on its board and its audit committee. Wagner most recently served as CFO of Millipore, prior to that firm's acquisition by Merck KGaA.